M
Michel Meignan
Researcher at University of Paris
Publications - 222
Citations - 10467
Michel Meignan is an academic researcher from University of Paris. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Positron emission tomography. The author has an hindex of 44, co-authored 210 publications receiving 8382 citations. Previous affiliations of Michel Meignan include Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington,N. George Mikhaeel,Lale Kostakoglu,Michel Meignan,Martin Hutchings,Stefan P. Müeller,Lawrence H. Schwartz,Emanuele Zucca,Richard I. Fisher,Judith Trotman,Otto S. Hoekstra,Rodney J. Hicks,Michael O'Doherty,Roland Hustinx,Alberto Biggi,Bruce D. Cheson +15 more
TL;DR: This article comprises the consensus reached to update guidance on the use of PET-CT for staging and response assessment for [18F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trials.
Journal ArticleDOI
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hervé Tilly,M. Gomes da Silva,Umberto Vitolo,Andrew Jack,Michel Meignan,Armando López-Guillermo,Jan Walewski,Marc André,Peter Johnson,Michael Pfreundschuh,Marco Ladetto +10 more
TL;DR: This work presents the results of a double-blind, placebo-controlled study conducted at the University of Southampton over a two-week period in June and July of last year that demonstrated clear trends in prognosis for breast cancer in smokers and women with a history of smoking.
Journal ArticleDOI
EANM guidelines for ventilation/perfusion scintigraphy : Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography.
TL;DR: V/PSPECT is strongly preferred to V/PPLANAR as the former permits the accurate diagnosis of PE even in the presence of comorbid diseases such as COPD and pneumonia.
Journal ArticleDOI
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma : Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
Marc André,Theodore Girinsky,Massimo Federico,Oumedaly Reman,Catherine Fortpied,Manuel Gotti,Olivier Casasnovas,Pauline Brice,Richard W.M. van der Maazen,Alessandro Re,Veronique Edeline,Christophe Fermé,Gustaaf W. van Imhoff,Francesco Merli,Reda Bouabdallah,Catherine Sebban,Lena Specht,Aspasia Stamatoullas,Richard Delarue,Valeria Fiaccadori,Monica Bellei,Tiana Raveloarivahy,Annibale Versari,Martin Hutchings,Michel Meignan,John M. M. Raemaekers +25 more
TL;DR: In stage I and II HL, PET response after two cycles of ABVD allows for early treatment adaptation when ePET is positive, and switching to BEACOPPesc + INRT significantly improved 5-year PFS.
Journal ArticleDOI
Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers,Marc André,Massimo Federico,Theodore Girinsky,Reman Oumedaly,Ercole Brusamolino,Pauline Brice,Christophe Fermé,Richard W.M. van der Maazen,Manuel Gotti,Reda Bouabdallah,Catherine Sebban,Yolande Lievens,Allessandro Re,Aspasia Stamatoullas,F. Morschhauser,Pieternella J. Lugtenburg,Elisabetta Abruzzese,Pierre Olivier,Rene-Olivier Casasnovas,Gustaaf W. van Imhoff,Tiana Raveloarivahy,Monica Bellei,Thierry Van der Borght,Stéphane Bardet,Annibale Versari,Martin Hutchings,Michel Meignan,Catherine Fortpied +28 more
TL;DR: Combined-modality treatment resulted in fewer early progressions in clinical stage I/II HL, although early outcome was excellent in both arms.